Concepedia

Michael Devitt

MD

10

Publications

410

Citations

10

H-Index

2016

Active since

Affiliations

University of Virginia(Current)

University of California, Los Angeles

Case Comprehensive Cancer Center

University of Utah

Instituto de Investigación Marqués de Valdecilla

Michael Devitt is an author at University of Virginia specializing in medicine, cancer therapeutics, and urology.

ORCID

Top concepts

Publications per year

2016–2024

10

Publications

10

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · Cancer · 2019 · 89 citations · Full text

Risk of Major Bleeding with Ibrutinib

J.N. Mock, Paul R. Kunk, Surabhi Palkimas et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 62 citations

, , +7

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · European Urology Oncology · 2021 · 60 citations · Full text

, , +7

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

Natalie Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos et al. · The Journal of Urology · 2020 · 58 citations · Full text

Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes

Stepan M. Esagian, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos et al. · British Journal of Urology · 2021 · 27 citations · Full text

Rows per page

1–5 of 10